Advanced glycation endproducts interfere with integrin-mediated osteoblastic attachment to a type-I collagen matrix
- Autores
- McCarthy, Antonio Desmond; Uemura, Toshimasa; Etcheverry, Susana Beatriz; Cortizo, Ana María
- Año de publicación
- 2004
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- The adhesion of osteoblasts to bone extracellular matrix, of which type-I collagen constitutes >85%, can modulate diverse aspects of their physiology such as growth, differentiation and mineralisation. In this study we examined the adhesion of UMR106 rat osteoblast-like cells either to a control (Col) or advanced-glycation-endproduct-modified (AGEs-Col) type I collagen matrix. We investigated the possible role of different integrin receptors in osteoblastic adhesion, by co-incubating these cells either with β-peptide (conserved sequence 113-125 of the β subunit of integrins) or with two other peptides, RGD (Arg-Gly-Asp) and DGEA (Asp-Gly-Glu-Ala), which are recognition sequences for the α-subunits of α1,5β1 and α2β1 integrins. Collagen glycation inhibited the adhesion of UMR106 osteoblasts to the matrix (40% reduction versus Col, P<0.001). β-Peptide showed a dose- and glycation-dependent inhibitory effect on adhesion, and at a concentration of 100μM decreased the attachment of UMR106 cells to both matrices (42% to Col, P<0.001; and 25% to AGEs-Col, P<0.01). The synthetic peptides RGD (1mM) and DGEA (5mM) inhibited the attachment of UMR106 cells to Col (30 and 20%, P<0.01 and P<0.001, respectively), but not to AGEs-Col. β-Peptide induced an increase in UMR106 cell clumping and a decrease in cellular spreading, while DGEA increased spreading with cellular extensions in multiple directions. These results indicate that both α and β integrin subunits participate in osteoblastic attachment to type-I collagen, probably through the α 1,5β1 and α2β1 integrins. AGEs-modification of type-I collagen impairs the integrin-mediated adhesion of osteoblastic cells to the matrix, and could thus contribute to the pathogenesis of diabetic osteopenia.
Fil: McCarthy, Antonio Desmond. Universidad Nacional de La Plata. Facultad de Ciencias Exactas. Departamento de Ciencias Biológicas. Cátedra Bioquímica Patológica; Argentina
Fil: Uemura, Toshimasa. National Institute of Advanced Industrial Science and Technology; Japón
Fil: Etcheverry, Susana Beatriz. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - La Plata. Centro de Química Inorgánica "Dr. Pedro J. Aymonino". Universidad Nacional de La Plata. Facultad de Ciencias Exactas. Centro de Química Inorgánica "Dr. Pedro J. Aymonino"; Argentina. Universidad Nacional de La Plata. Facultad de Ciencias Exactas. Departamento de Ciencias Biológicas. Cátedra Bioquímica Patológica; Argentina
Fil: Cortizo, Ana María. Universidad Nacional de La Plata. Facultad de Ciencias Exactas. Departamento de Ciencias Biológicas. Cátedra Bioquímica Patológica; Argentina - Materia
-
ADVANCED GLYCATION ENDPRODUCTS
AGES
ARG-GLY-ASP
ASP-GLY-GLU-ALA
DGEA
DMEM
DULBECCO'S MODIFIED EAGLE'S MEDIUM
ECM
EDTA
ETHYLENEDIAMINO-TETRA-ACETIC ACID
EXTRACELLULAR MATRIX
FBS
FETAL BOVINE SERUM
PBS
PHOSPHATE BUFFERED SALINE SOLUTION
RGD - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
- Repositorio
- Institución
- Consejo Nacional de Investigaciones Científicas y Técnicas
- OAI Identificador
- oai:ri.conicet.gov.ar:11336/181525
Ver los metadatos del registro completo
id |
CONICETDig_e78b628c5473a8dde94467029d85413a |
---|---|
oai_identifier_str |
oai:ri.conicet.gov.ar:11336/181525 |
network_acronym_str |
CONICETDig |
repository_id_str |
3498 |
network_name_str |
CONICET Digital (CONICET) |
spelling |
Advanced glycation endproducts interfere with integrin-mediated osteoblastic attachment to a type-I collagen matrixMcCarthy, Antonio DesmondUemura, ToshimasaEtcheverry, Susana BeatrizCortizo, Ana MaríaADVANCED GLYCATION ENDPRODUCTSAGESARG-GLY-ASPASP-GLY-GLU-ALADGEADMEMDULBECCO'S MODIFIED EAGLE'S MEDIUMECMEDTAETHYLENEDIAMINO-TETRA-ACETIC ACIDEXTRACELLULAR MATRIXFBSFETAL BOVINE SERUMPBSPHOSPHATE BUFFERED SALINE SOLUTIONRGDhttps://purl.org/becyt/ford/3.1https://purl.org/becyt/ford/3The adhesion of osteoblasts to bone extracellular matrix, of which type-I collagen constitutes >85%, can modulate diverse aspects of their physiology such as growth, differentiation and mineralisation. In this study we examined the adhesion of UMR106 rat osteoblast-like cells either to a control (Col) or advanced-glycation-endproduct-modified (AGEs-Col) type I collagen matrix. We investigated the possible role of different integrin receptors in osteoblastic adhesion, by co-incubating these cells either with β-peptide (conserved sequence 113-125 of the β subunit of integrins) or with two other peptides, RGD (Arg-Gly-Asp) and DGEA (Asp-Gly-Glu-Ala), which are recognition sequences for the α-subunits of α1,5β1 and α2β1 integrins. Collagen glycation inhibited the adhesion of UMR106 osteoblasts to the matrix (40% reduction versus Col, P<0.001). β-Peptide showed a dose- and glycation-dependent inhibitory effect on adhesion, and at a concentration of 100μM decreased the attachment of UMR106 cells to both matrices (42% to Col, P<0.001; and 25% to AGEs-Col, P<0.01). The synthetic peptides RGD (1mM) and DGEA (5mM) inhibited the attachment of UMR106 cells to Col (30 and 20%, P<0.01 and P<0.001, respectively), but not to AGEs-Col. β-Peptide induced an increase in UMR106 cell clumping and a decrease in cellular spreading, while DGEA increased spreading with cellular extensions in multiple directions. These results indicate that both α and β integrin subunits participate in osteoblastic attachment to type-I collagen, probably through the α 1,5β1 and α2β1 integrins. AGEs-modification of type-I collagen impairs the integrin-mediated adhesion of osteoblastic cells to the matrix, and could thus contribute to the pathogenesis of diabetic osteopenia.Fil: McCarthy, Antonio Desmond. Universidad Nacional de La Plata. Facultad de Ciencias Exactas. Departamento de Ciencias Biológicas. Cátedra Bioquímica Patológica; ArgentinaFil: Uemura, Toshimasa. National Institute of Advanced Industrial Science and Technology; JapónFil: Etcheverry, Susana Beatriz. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - La Plata. Centro de Química Inorgánica "Dr. Pedro J. Aymonino". Universidad Nacional de La Plata. Facultad de Ciencias Exactas. Centro de Química Inorgánica "Dr. Pedro J. Aymonino"; Argentina. Universidad Nacional de La Plata. Facultad de Ciencias Exactas. Departamento de Ciencias Biológicas. Cátedra Bioquímica Patológica; ArgentinaFil: Cortizo, Ana María. Universidad Nacional de La Plata. Facultad de Ciencias Exactas. Departamento de Ciencias Biológicas. Cátedra Bioquímica Patológica; ArgentinaPergamon-Elsevier Science Ltd2004-05info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/181525McCarthy, Antonio Desmond; Uemura, Toshimasa; Etcheverry, Susana Beatriz; Cortizo, Ana María; Advanced glycation endproducts interfere with integrin-mediated osteoblastic attachment to a type-I collagen matrix; Pergamon-Elsevier Science Ltd; International Journal of Biochemistry and Cellular Biology; 36; 5; 5-2004; 840-8481357-2725CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/url/https://www.sciencedirect.com/science/article/abs/pii/S1357272503003169info:eu-repo/semantics/altIdentifier/doi/10.1016/j.biocel.2003.09.006info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-29T09:51:39Zoai:ri.conicet.gov.ar:11336/181525instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-29 09:51:39.862CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
dc.title.none.fl_str_mv |
Advanced glycation endproducts interfere with integrin-mediated osteoblastic attachment to a type-I collagen matrix |
title |
Advanced glycation endproducts interfere with integrin-mediated osteoblastic attachment to a type-I collagen matrix |
spellingShingle |
Advanced glycation endproducts interfere with integrin-mediated osteoblastic attachment to a type-I collagen matrix McCarthy, Antonio Desmond ADVANCED GLYCATION ENDPRODUCTS AGES ARG-GLY-ASP ASP-GLY-GLU-ALA DGEA DMEM DULBECCO'S MODIFIED EAGLE'S MEDIUM ECM EDTA ETHYLENEDIAMINO-TETRA-ACETIC ACID EXTRACELLULAR MATRIX FBS FETAL BOVINE SERUM PBS PHOSPHATE BUFFERED SALINE SOLUTION RGD |
title_short |
Advanced glycation endproducts interfere with integrin-mediated osteoblastic attachment to a type-I collagen matrix |
title_full |
Advanced glycation endproducts interfere with integrin-mediated osteoblastic attachment to a type-I collagen matrix |
title_fullStr |
Advanced glycation endproducts interfere with integrin-mediated osteoblastic attachment to a type-I collagen matrix |
title_full_unstemmed |
Advanced glycation endproducts interfere with integrin-mediated osteoblastic attachment to a type-I collagen matrix |
title_sort |
Advanced glycation endproducts interfere with integrin-mediated osteoblastic attachment to a type-I collagen matrix |
dc.creator.none.fl_str_mv |
McCarthy, Antonio Desmond Uemura, Toshimasa Etcheverry, Susana Beatriz Cortizo, Ana María |
author |
McCarthy, Antonio Desmond |
author_facet |
McCarthy, Antonio Desmond Uemura, Toshimasa Etcheverry, Susana Beatriz Cortizo, Ana María |
author_role |
author |
author2 |
Uemura, Toshimasa Etcheverry, Susana Beatriz Cortizo, Ana María |
author2_role |
author author author |
dc.subject.none.fl_str_mv |
ADVANCED GLYCATION ENDPRODUCTS AGES ARG-GLY-ASP ASP-GLY-GLU-ALA DGEA DMEM DULBECCO'S MODIFIED EAGLE'S MEDIUM ECM EDTA ETHYLENEDIAMINO-TETRA-ACETIC ACID EXTRACELLULAR MATRIX FBS FETAL BOVINE SERUM PBS PHOSPHATE BUFFERED SALINE SOLUTION RGD |
topic |
ADVANCED GLYCATION ENDPRODUCTS AGES ARG-GLY-ASP ASP-GLY-GLU-ALA DGEA DMEM DULBECCO'S MODIFIED EAGLE'S MEDIUM ECM EDTA ETHYLENEDIAMINO-TETRA-ACETIC ACID EXTRACELLULAR MATRIX FBS FETAL BOVINE SERUM PBS PHOSPHATE BUFFERED SALINE SOLUTION RGD |
purl_subject.fl_str_mv |
https://purl.org/becyt/ford/3.1 https://purl.org/becyt/ford/3 |
dc.description.none.fl_txt_mv |
The adhesion of osteoblasts to bone extracellular matrix, of which type-I collagen constitutes >85%, can modulate diverse aspects of their physiology such as growth, differentiation and mineralisation. In this study we examined the adhesion of UMR106 rat osteoblast-like cells either to a control (Col) or advanced-glycation-endproduct-modified (AGEs-Col) type I collagen matrix. We investigated the possible role of different integrin receptors in osteoblastic adhesion, by co-incubating these cells either with β-peptide (conserved sequence 113-125 of the β subunit of integrins) or with two other peptides, RGD (Arg-Gly-Asp) and DGEA (Asp-Gly-Glu-Ala), which are recognition sequences for the α-subunits of α1,5β1 and α2β1 integrins. Collagen glycation inhibited the adhesion of UMR106 osteoblasts to the matrix (40% reduction versus Col, P<0.001). β-Peptide showed a dose- and glycation-dependent inhibitory effect on adhesion, and at a concentration of 100μM decreased the attachment of UMR106 cells to both matrices (42% to Col, P<0.001; and 25% to AGEs-Col, P<0.01). The synthetic peptides RGD (1mM) and DGEA (5mM) inhibited the attachment of UMR106 cells to Col (30 and 20%, P<0.01 and P<0.001, respectively), but not to AGEs-Col. β-Peptide induced an increase in UMR106 cell clumping and a decrease in cellular spreading, while DGEA increased spreading with cellular extensions in multiple directions. These results indicate that both α and β integrin subunits participate in osteoblastic attachment to type-I collagen, probably through the α 1,5β1 and α2β1 integrins. AGEs-modification of type-I collagen impairs the integrin-mediated adhesion of osteoblastic cells to the matrix, and could thus contribute to the pathogenesis of diabetic osteopenia. Fil: McCarthy, Antonio Desmond. Universidad Nacional de La Plata. Facultad de Ciencias Exactas. Departamento de Ciencias Biológicas. Cátedra Bioquímica Patológica; Argentina Fil: Uemura, Toshimasa. National Institute of Advanced Industrial Science and Technology; Japón Fil: Etcheverry, Susana Beatriz. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - La Plata. Centro de Química Inorgánica "Dr. Pedro J. Aymonino". Universidad Nacional de La Plata. Facultad de Ciencias Exactas. Centro de Química Inorgánica "Dr. Pedro J. Aymonino"; Argentina. Universidad Nacional de La Plata. Facultad de Ciencias Exactas. Departamento de Ciencias Biológicas. Cátedra Bioquímica Patológica; Argentina Fil: Cortizo, Ana María. Universidad Nacional de La Plata. Facultad de Ciencias Exactas. Departamento de Ciencias Biológicas. Cátedra Bioquímica Patológica; Argentina |
description |
The adhesion of osteoblasts to bone extracellular matrix, of which type-I collagen constitutes >85%, can modulate diverse aspects of their physiology such as growth, differentiation and mineralisation. In this study we examined the adhesion of UMR106 rat osteoblast-like cells either to a control (Col) or advanced-glycation-endproduct-modified (AGEs-Col) type I collagen matrix. We investigated the possible role of different integrin receptors in osteoblastic adhesion, by co-incubating these cells either with β-peptide (conserved sequence 113-125 of the β subunit of integrins) or with two other peptides, RGD (Arg-Gly-Asp) and DGEA (Asp-Gly-Glu-Ala), which are recognition sequences for the α-subunits of α1,5β1 and α2β1 integrins. Collagen glycation inhibited the adhesion of UMR106 osteoblasts to the matrix (40% reduction versus Col, P<0.001). β-Peptide showed a dose- and glycation-dependent inhibitory effect on adhesion, and at a concentration of 100μM decreased the attachment of UMR106 cells to both matrices (42% to Col, P<0.001; and 25% to AGEs-Col, P<0.01). The synthetic peptides RGD (1mM) and DGEA (5mM) inhibited the attachment of UMR106 cells to Col (30 and 20%, P<0.01 and P<0.001, respectively), but not to AGEs-Col. β-Peptide induced an increase in UMR106 cell clumping and a decrease in cellular spreading, while DGEA increased spreading with cellular extensions in multiple directions. These results indicate that both α and β integrin subunits participate in osteoblastic attachment to type-I collagen, probably through the α 1,5β1 and α2β1 integrins. AGEs-modification of type-I collagen impairs the integrin-mediated adhesion of osteoblastic cells to the matrix, and could thus contribute to the pathogenesis of diabetic osteopenia. |
publishDate |
2004 |
dc.date.none.fl_str_mv |
2004-05 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/181525 McCarthy, Antonio Desmond; Uemura, Toshimasa; Etcheverry, Susana Beatriz; Cortizo, Ana María; Advanced glycation endproducts interfere with integrin-mediated osteoblastic attachment to a type-I collagen matrix; Pergamon-Elsevier Science Ltd; International Journal of Biochemistry and Cellular Biology; 36; 5; 5-2004; 840-848 1357-2725 CONICET Digital CONICET |
url |
http://hdl.handle.net/11336/181525 |
identifier_str_mv |
McCarthy, Antonio Desmond; Uemura, Toshimasa; Etcheverry, Susana Beatriz; Cortizo, Ana María; Advanced glycation endproducts interfere with integrin-mediated osteoblastic attachment to a type-I collagen matrix; Pergamon-Elsevier Science Ltd; International Journal of Biochemistry and Cellular Biology; 36; 5; 5-2004; 840-848 1357-2725 CONICET Digital CONICET |
dc.language.none.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/url/https://www.sciencedirect.com/science/article/abs/pii/S1357272503003169 info:eu-repo/semantics/altIdentifier/doi/10.1016/j.biocel.2003.09.006 |
dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
dc.format.none.fl_str_mv |
application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
Pergamon-Elsevier Science Ltd |
publisher.none.fl_str_mv |
Pergamon-Elsevier Science Ltd |
dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
reponame_str |
CONICET Digital (CONICET) |
collection |
CONICET Digital (CONICET) |
instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
_version_ |
1844613587635535872 |
score |
13.070432 |